An overview of fungal infections

Drugs

Volumn 61, Issue SUPPL. 1, 2001, Pages 1-12

  Garber, G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLOSIS; ASPERGILLUS; CANDIDA ALBICANS; CANDIDIASIS; CONFERENCE PAPER; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DERMATOMYCOSIS; ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; MYCOSIS; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTION;

ASPERGILLUS; CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0035137830     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161001-00001     Document Type: Conference Paper

References (89)

1. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
2. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation
3. Fungal infections in bone marrow transplant patients
4. Fungal contamination of the floors of swimming pools, particularly subtropical swimming paradises
5. Treatment and prophylaxis of tinea infections
6. Tinea pedis: Clinical experience and efficacy of short treatment
7. Association of athlete's foot with cellulitis of the lower extremities: Diagnostic value of bacterial cultures of ipsilateral interdigital space samples
8. Tinea capitis: A current perspective
9. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago
10. Tinea capitis in southeast London - A new pattern of infection with public health implications
11. Diagnosis and treatment of tinea versicolor
12. Epidemiology, diagnosis, and management of Malassezia furfur systemic infection
13. Newer systemic antifungal drugs for the treatment of onychomycosis
14. Epidemiology of onychomycosis in special-risk populations
15. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey
16. Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases
17. Non-dermatophytes in onychomycosis of the toenails
18. Evolving role of nondermatophytes in onychomycosis [review]
19. Quality of life measurement in dermatology: A practical guide
20. Dermatology quality of life scales - A measure of the impact of skin diseases
21. Onychomycosis: A significant and important disease
22. Effect of onychomycosis on quality of life
23. Onychomycosis is more than a cosmetic problem
24. Quality of life of persons with onychomycosis
25. Comparison of strain specificity of yeasts from various organs of women with vaginal candidiasis
26. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis
27. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis
28. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection
29. Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: A critical reassessment
30. Oral candidiasis: The clinical challenge of resistance and management
31. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
32. Fungal infection in Latin American countries
33. Treatment of sporotrichosis with itraconazole
34. Cutaneous manifestations of fungal infection
35. Chromoblastomycosis: A retrospective study of 325 cases on Amazonic Region
36. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both
37. Chronic mucocutaneous candidiasis I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production
38. Chronic mucocutaneous candidiasis II. Class and subclass of specific antibody responses in vivo and in vitro
39. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990 National Nosocomial Infections Surveillance System
40. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993
41. Symposium on infectious complications of neoplastic disease (Part II) Chemoprophylaxis of fungal infections
42. Fungal infections in cancer patients: An international autopsy survey
43. Fungal infections in solid organ transplant recipients
44. Fungal infections in lung and heart-lung transplant recipients, Report of 9 cases and review of the literature
45. Management of candida septicaemia in a regional burn unit
46. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis
47. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature
48. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients
49. Compliance with handwashing in a teaching hospital. Infection Control Program
50. Fungal infections associated with malignancies, treatments and AIDS
51. Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection
52. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
53. Infection due to Penicillium marneffei, an emerging pathogen: Review of 155 reported cases
54. Fungal infection in chronic granulomatou s disease. The importance of the phagocyte in defense against fungi
55. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies
56. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
57. Detection and identification of fungal pathogens in blood by using molecular probes
58. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
59. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
60. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study
61. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
62. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
63. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
64. Importance of Candida species other than C. albicans as pathogens in oncology patients
65. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
66. Epidemiological shifts in opportunistic and nosocomial Candida infections: Mycological aspects
67. The epidemiology of hematogenous candidiasis caused by different Candida species
68. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
69. The contribution of fluconazole to the changing epidemiology of invasive candidal infections
70. Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis and treatment
71. Aspergillus in pepper
72. Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: A European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the Intergroupe Francais du Myelome
73. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients
74. Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993)
75. Fatal biphasic brainstem and spinal leptomeningitis with Cryptococcus neoformans in a non-immunocompromised child
76. Cryptococcal disease of the CNS in immunocompetent hosts: Influence of cryptococcal variety on clinical manifestations and outcome
77. Epidemiology of nosocomial fungal infections
78. Invasive yeast infections other than Candida spp. in acute leukaemia
79. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
80. Mucormycosis
81. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases
82. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises Case 38-1982 A 66-year-old diabetic woman with sinusitis and cranial-nerve abnormalities
83. Systemic mycoses in the United States, 1980-1982
84. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis
85. Coccidioidomycosis: A reemerging infectious disease
86. Endemic mycoses: A treatment update
87. Symptoms and routine laboratory abnormalities associated with coccidioidomycosis
88. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises Case 21-1994 A 20-year-old Mexican immigrant with recurrent hemoptysis and a pulmonary cavitary lesion